MYOTONIC DYSTROPHY
Clinical trials for MYOTONIC DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new MYOTONIC DYSTROPHY trials appear
Sign up with your email to follow new studies for MYOTONIC DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise in early trial for rare muscle disease
Disease control CompletedThis study tested a new medicine called AOC 1001 in 38 adults with myotonic dystrophy type 1 (DM1), a genetic disease that causes muscle weakness and stiffness. The goal was to see if the drug is safe and how it works in the body. Participants received either the drug or a placeb…
Matched conditions: MYOTONIC DYSTROPHY
Phase: PHASE1, PHASE2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Experimental DM1 drug shows promise in long-term safety trial
Disease control CompletedThis study looked at the long-term safety of a drug called AOC 1001 in adults with myotonic dystrophy type 1 (DM1), a genetic muscle disease. 37 people who completed an earlier study received multiple doses of the drug by IV. Researchers tracked side effects and measured drug lev…
Matched conditions: MYOTONIC DYSTROPHY
Phase: PHASE2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
Heart danger in muscle disease: 537 patients tracked for sudden death
Knowledge-focused CompletedThis study followed 537 adults with myotonic dystrophy type 1 for two years to see how often serious heart rhythm problems or sudden death occur. Researchers used noninvasive and invasive tests to find factors that might predict these events. The goal was to better understand and…
Matched conditions: MYOTONIC DYSTROPHY
Phase: NA • Sponsor: Catholic University of the Sacred Heart • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC